Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?
Publication
, Journal Article
Giganti, F; Gupta, RT
Published in: AJR Am J Roentgenol
October 2024
Duke Scholars
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
October 2024
Volume
223
Issue
4
Start / End Page
e2430973
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Giganti, F., & Gupta, R. T. (2024). Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA? AJR Am J Roentgenol, 223(4), e2430973. https://doi.org/10.2214/AJR.24.30973
Giganti, Francesco, and Rajan T. Gupta. “Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?” AJR Am J Roentgenol 223, no. 4 (October 2024): e2430973. https://doi.org/10.2214/AJR.24.30973.
Giganti F, Gupta RT. Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA? AJR Am J Roentgenol. 2024 Oct;223(4):e2430973.
Giganti, Francesco, and Rajan T. Gupta. “Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA?” AJR Am J Roentgenol, vol. 223, no. 4, Oct. 2024, p. e2430973. Pubmed, doi:10.2214/AJR.24.30973.
Giganti F, Gupta RT. Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA? AJR Am J Roentgenol. 2024 Oct;223(4):e2430973.
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
October 2024
Volume
223
Issue
4
Start / End Page
e2430973
Location
United States
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences